Henry Schein, Inc. (HSIC) - What Are Analysts Saying About This Stock?

Key Points

• Analysts’ consensus is “Moderate Buy”: Of 15 analysts covering Henry Schein, nine recommend buying, five rate it a hold, and one recommends selling. The average 12-month price target is $93.27, versus a recent share price of $86.00.
• Institutional ownership remains high, with institutional investors holding 96.62% of the company’s outstanding shares; several hedge funds recently increased their positions.
• Henry Schein exceeded quarterly expectations, reporting $1.27 in EPS and $3.46 billion in revenue, with revenue up 6.7% year over year. Analysts expect about $5.36 in EPS for the current fiscal year, within the company’s $5.29–$5.39 guidance range.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fifteen analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $93.27.

HSIC has been the subject of several research reports. UBS Group set a $94.00 price objective on shares of Henry Schein and gave the company a "neutral" rating in a research report on Wednesday, August 5th. Weiss Ratings upgraded shares of Henry Schein from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Friday, August 21st. Leerink Partners set a $92.00 price target on shares of Henry Schein and gave the company a "market perform" rating in a research note on Wednesday, October 14th. Stifel Nicolaus set a $95.00 price target on shares of Henry Schein in a report on Wednesday, August 5th. Finally, Wall Street Zen raised shares of Henry Schein from a "hold" rating to a "buy" rating in a report on Monday, August 17th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HSIC. Parallel Advisors LLC boosted its holdings in Henry Schein by 12.7% in the first quarter. Parallel Advisors LLC now owns 1,314 shares of the company's stock valued at $97,000 after acquiring an additional 148 shares during the last quarter. Mufg Securities Americas Inc. increased its position in Henry Schein by 5.3% in the second quarter. Mufg Securities Americas Inc. now owns 2,917 shares of the company's stock worth $244,000 after purchasing an additional 148 shares during the period. New Mexico Educational Retirement Board increased its position in Henry Schein by 4.2% in the second quarter. New Mexico Educational Retirement Board now owns 4,950 shares of the company's stock worth $413,000 after purchasing an additional 200 shares during the period. Czech National Bank raised its holdings in Henry Schein by 1.1% during the 2nd quarter. Czech National Bank now owns 27,561 shares of the company's stock worth $2,302,000 after purchasing an additional 308 shares during the last quarter. Finally, Blackhawk Capital Partners LLC raised its holdings in Henry Schein by 8.7% during the 1st quarter. Blackhawk Capital Partners LLC now owns 4,665 shares of the company's stock worth $344,000 after purchasing an additional 374 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

Shares of HSIC stock opened at $86.00 on Friday. The stock's fifty day moving average is $87.05 and its 200-day moving average is $82.57. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.73 and a current ratio of 1.32. The stock has a market capitalization of $9.58 billion, a PE ratio of 25.07, a PEG ratio of 1.53 and a beta of 0.84. Henry Schein has a 52 week low of $62.15 and a 52 week high of $92.18.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.03. The business had revenue of $3.46 billion during the quarter, compared to analysts' expectations of $3.37 billion. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%. The firm's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.10 earnings per share. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Equities research analysts expect that Henry Schein will post 5.36 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc NASDAQ: HSIC is a global provider of healthcare products and services serving dental and medical professionals, as well as veterinary practices and laboratories. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used in clinical and practice-management settings.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support clinical workflows, electronic health records, practice management, procurement, equipment installation, and technical support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.